Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Tables)

v3.21.1
Share Capital (Tables)
 12 Months Ended
Dec. 31, 2020
Share Capital (Tables) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
December 31,2020  
Options outstanding     Options exercisable  
Exercise prices *     Number of
options
outstanding
at end of year		     Weighted
average
remaining
contractual Life		     Number of
options
exercisable
at end of year		     Weighted
average
remaining
contractual life		  
$ 65.06       1,333       0.13       1,333       0.13  
  64.85       1,333       0.13       1,333       0.13  
  27.99       6,666       4.38       1,329       4.33  
  6.84       5,000       4.33       -       -  
  11.06       162,713       9.11       -       -  
  10.08       309,409       9.41       -       -  
  9.12       32,000       9.66       -       -  
  5.07       239,250       2.65       103,963       1.48  
$ 4.02       459,155       4.07       357,217       4.02  
          1,216,859                          
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]
    Year ended December 31  
    2020     2019     2018  
Cost of revenues   $ 66     $ -     $ -  
Research and development expenses     464       549     $ 457  
General, administrative and marketing expenses     1,075       576       977  
    $ 1,605     $ 1,125     $ 1,434  
Option Granted to Employees [Member]  
Share Capital (Tables) [Line Items]  
Schedule of shares issued granted options
    Year ended December 31, 2020  
    Award amount     Exercise price range     Vesting period     Expiration  
Employees     317,909       $ 10.08       4 years       10 years  
Directors     194,713       $ 9.12-11.06       4 years       10 years  
    Year ended December 31, 2019  
    Award amount     Exercise price range     Vesting period     Expiration  
Employees     230,000       $ 5.07       4 years       7 years  
Directors     301,390       $ 4.02-$5.07       4 years       7 years  
    Year ended December 31, 2018  
    Award amount     Exercise price Range*     Vesting period     Expiration  
Employees     93,000     $ 5.87       4 years       7 years  
Directors     63,000     $ 7.74       4 years       7 years  
Schedule of fair value options granted
    2020     2019     2018  
Value of one ordinary share   $ 7.86-10.5     $ 5.7-$5.93     $ 5.34-$7.83  
Dividend yield     0 %     0 %     0 %
Expected volatility     66.12-66.41 %     61.31%-62.56 %     62.63 %
Risk-free interest rate     0.45-0.52 %     2 %     2 %
Expected term     6.11 years       4-5.5 years       4 years  
Schedule of Weighted Average Number of Shares [Table Text Block]
    2020     2019     2018  
    Number of options     Weighted average exercise price     Number of options     Weighted average exercise price*     Number of options     Weighted average exercise price*  
Options outstanding at the beginning of the year     721,361     $ 4.38       512,615     $ 15.09       385,115     $ 17.68  
Granted     512,622       10.33       531,390       5.09       156,000       7.55  
Exercised     (20,245 )     4.13       (6,076 )     1.30       -       -  
Expired     -       -       (11,891 )     23.83       (2,500 )     24.01  
Forfeited     (14,961 )     7.93       (304,677 )     5.84       (26,000 )     7.42  
Options outstanding at the end of the year     1,198,777       6.88       721,361     $ 4.38 *     512,615     $ 15.09  
Options exercisable at the end of the year     477,611     $ 4.25       310,093     $ 4.02 *     211,906     $ 20.28  
Option Granted to Non-Employees [Member]  
Share Capital (Tables) [Line Items]  
Schedule of fair value options granted
    2020     2019     2018  
Value of one ordinary share   $ -     $ 5.93       5.36  
Dividend yield     -       0 %     0 %
Expected volatility     -       62 %     58 %
Risk-free interest rate     -       2 %     2 %
Expected term     -       4 years       4 years  
Schedule of Weighted Average Number of Shares [Table Text Block]
    2020     2019     2018  
    Number of options     Weighted average exercise price     Number of options     Weighted average exercise price*     Number of options     Weighted average exercise price*  
Options outstanding at the beginning of the year     23,664     $ 27.44       18,664     $ 33.44       13,664     $ 43.52  
Granted     -       -       5,000       5.07       5,000       5.87  
Exercised     (1,250 )     5.07       -       -       -       -  
Expired     (4,332 )     61.85       -       -       -       -  
Options outstanding at the end of the year     18,082     $ 17.97       23,664     $ 27.44       18,664     $ 33.44  
Options exercisable at the end of the year     8,057     $ 18.42       10,202     $ 46.03       8,165     $ 51.21